Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway
Authors
Keywords
Osteosarcoma, Sulforaphane, FSTL1, NF-κB, Progression
Journal
LIFE SCIENCES
Volume 263, Issue -, Pages 118485
Publisher
Elsevier BV
Online
2020-10-02
DOI
10.1016/j.lfs.2020.118485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
- (2020) Bin Zhang et al. Journal of Orthopaedic Surgery and Research
- Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-κB Inhibition and Nrf2/HO-1 Activation
- (2019) Lalita Subedi et al. Cells
- Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-κB pathway
- (2019) Jianguo Zhou et al. ACTA HISTOCHEMICA
- Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin
- (2019) Jean Chiou et al. CANCER RESEARCH
- Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway
- (2019) Chuan Zhang et al. Drug Design Development and Therapy
- Follistatin-like 1 in development and human diseases
- (2018) Andrea Mattiotti et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation
- (2018) Haina Wang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway
- (2018) Chuansha Gu et al. Cell Death & Disease
- Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells
- (2018) Ming Li et al. Frontiers in Pharmacology
- Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
- (2018) Amanda J. Saraf et al. Frontiers in Oncology
- Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity
- (2018) Chie Kudo-Saito et al. Cell Reports
- Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1
- (2016) Ming Yang et al. BREAST CANCER RESEARCH AND TREATMENT
- Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization
- (2016) Sanguine Byun et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
- (2015) FENGMING LAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction
- (2013) C. Kudo-Saito et al. CANCER RESEARCH
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics
- (2013) LING YU et al. Oncology Letters
- FSTL1 promotes bone metastasis by causing immune dysfunction
- (2013) Chie Kudo-Saito OncoImmunology
- NF-κB in immunobiology
- (2011) Matthew S Hayden et al. CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now